Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.

Mestag Therapeutics ("Mestag”), a biotech company harnessing fibroblast immunology to develop impactful treatments for ...

March 15, 2026 expert reaction to conference abstract comparing prostate cancer and breast cancer screening programmes, being presented at the European Association of Urology Cong ...

Bacon may be one of America’s favorite breakfast foods, but research suggests certain processed varieties could carry health ...

The technology is available on the new MyLab™E85 GTS Edition that will be showcased together with the brand new MyLab™C30 GTS ...

Company plans to initiate a pivotal phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with progressive, ...

URO-1, Inc. is a life sciences company dedicated to advancing the tools and workflows used in soft tissue biopsy diagnostics.

Dr. Raza Bokhari, Executive Chairman & CEO will participate in panel discussions and highlight Company's AI-enabled Drug ...

Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that returned after radiotherapy. Matched analyses estimated 10-year ...

Source: Getty Images Using the US nationwide Epic Cosmos database, investigators analyzed over 420,000 real-world BPH procedures performed from 2014 to 2024. In a real-world study, minimally invasive ...

Because treatment of the whole prostate can lead to long-term side effects in patients with prostate cancer, interest in minimally invasive, focal treatment options has been growing for certain ...